Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous midazolam added to dual postoperative nausea and vomiting prophylaxis in breast surgery
TCTR20220510001Phase 4Completed
- Sponsor
- Chulalongkorn University
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of midazolam in postoperative nausea and vomiting (PONV), sponsored by Chulalongkorn University. Started May 2022; status: completed.
02
Drugs
midazolam
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on TCTR20220510001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220510001.